Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    "22q11.2 deletion syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition: 22q11.2 Deletion Syndrome
Interventions: Drug: NFC-1;   Drug: Placebo
2 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
Intervention:
3 Completed Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
Conditions: Immune Defect;   22q11.2 Deletion Syndrome
Intervention:
4 Terminated Serum-Free Thymus Transplantation in DiGeorge Anomaly
Condition: DiGeorge Anomaly
Interventions: Biological: Serum Free Thymus Transplantation with Immunosuppression;   Other: Serum Free Thymus Transplantation without immunosuppression
5 Completed Cognitive Remediation in 22q11DS
Conditions: 22q11.2 Deletion Syndrome;   Velo-Cardio-Facial Syndrome
Interventions: Behavioral: Cognitive remediation program;   Behavioral: Small group social skills training
6 Active, not recruiting Thymus Transplantation in DiGeorge Syndrome #668
Conditions: DiGeorge Syndrome;   Complete Typical DiGeorge Anomaly
Intervention: Biological: Thymus Tissue for Transplantation
7 Unknown  Genetic Modifiers for 22q11.2 Syndrome
Condition: 22q11.2 Deletion Syndrome
Intervention: Other: Observation
8 Completed Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome
Condition: Ear Malformations in the Velocardiofacial Syndrome
Intervention:
9 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
10 Completed Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome
Condition: Velocardiofacial Syndrome
Intervention: Behavioral: Challenging Our Minds Program
11 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
12 Recruiting The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone
13 Active, not recruiting Parathyroid and Thymus Transplantation in DiGeorge #931
Conditions: DiGeorge Syndrome;   Hypoparathyroidism;   Complete DiGeorge Syndrome
Intervention: Biological: Thymus/Parathyroid Transplantation
14 Terminated Infection in DiGeorge Following CHD Surgery
Conditions: DiGeorge Syndrome;   Congenital Heart Defects
Intervention:
15 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects
Intervention:
16 Active, not recruiting Thymus Transplantation Dose in DiGeorge #932
Conditions: DiGeorge Anomaly;   DiGeorge Syndrome;   Complete DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Parathyroid Tissue for Transplantation
17 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
18 Recruiting Non-Invasive Chromosomal Evaluation of 22q11.2
Condition: DiGeorge Syndrome, Velocardiofacial Syndrome, 22q.11.2 Deletion Syndrome
Intervention:
19 Completed Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
Conditions: DiGeorge Syndrome;   Velocardiofacial Syndrome;   22q11.2 Syndrome
Intervention:
20 Active, not recruiting Effects of PTH Replacement on Bone in Hypoparathyroidism
Conditions: Hypoparathyroidism;   DiGeorge Syndrome
Intervention: Drug: PTH 1-34

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.